BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4062941)

  • 1. Restorative effects of defective autologous lymphocyte cytotoxicity by calmodulin antagonists.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Biochem Biophys Res Commun; 1985 Oct; 132(2):620-7. PubMed ID: 4062941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human fibroblast interferon on the cytotoxic activity of natural killer cells and lymphocytes against autochthonous and allogeneic tumor cells.
    Ezaki K; Okabe K; Domyo M; Abe K; Kubokawa C; Ogawa M
    Gan; 1983 Oct; 74(5):723-9. PubMed ID: 6227516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the involvement of calmodulin in natural cytotoxicity using a range of calmodulin antagonists of varying potency and improved specificity.
    Rees RC; Parker S; Platts A; Blackburn MG; MacNeil S
    Biosci Rep; 1987 Oct; 7(10):771-5. PubMed ID: 2833953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell cytotoxicity: role of calmodulin.
    Rochette-Egly C; Tovey MG
    Biochem Biophys Res Commun; 1984 Jun; 121(2):478-86. PubMed ID: 6203532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
    Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
    Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G; Zimmerman TP
    Mol Pharmacol; 1984 Sep; 26(2):286-92. PubMed ID: 6482875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
    Kikuchi Y; Iwano I; Kato K
    Biochem Biophys Res Commun; 1984 Aug; 123(1):385-92. PubMed ID: 6541042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of calmodulin in human natural killer cell activity.
    Moon TD; Morley JE; Vessella RL; Lange PH
    Scand J Immunol; 1983 Sep; 18(3):255-8. PubMed ID: 6622981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antineoplastic effects of cisplatin by calmodulin antagonists in nude mice bearing human ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Hirata J; Kita T; Miyauchi M; Kato K
    Cancer Res; 1987 Dec; 47(24 Pt 1):6459-61. PubMed ID: 3677086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
    Nauta MM; Boven E; Schlüper HM; Erkelens CA; Pinedo HM
    Br J Cancer; 1986 Aug; 54(2):331-5. PubMed ID: 3017398
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cimetidine on tumor growth and immune function in nude mice bearing human ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    J Natl Cancer Inst; 1985 Feb; 74(2):495-8. PubMed ID: 3871872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killing against ovarian carcinoma.
    Shau H; Koren HS; Dawson JR
    Br J Cancer; 1983 May; 47(5):687-95. PubMed ID: 6573908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
    Kikuchi Y; Iwano I; Miyauchi M; Sasa H; Nagata I; Kuki E
    Gynecol Oncol; 1990 Nov; 39(2):199-203. PubMed ID: 2227596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
    Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. III. Cytotoxic potential in vitro and characterization of antigen(s).
    Kutteh WH; Baker VV; Doellgast GJ
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1301-6. PubMed ID: 2220942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of lymphokine-activated killer cells against fresh human leukemia cells.
    Tahara T; Iseki R; Morishima Y; Yokomaku S; Ohno R; Saito H
    Jpn J Cancer Res; 1988 Mar; 79(3):390-9. PubMed ID: 3131287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.